ArTS Archivio della ricerca di Trieste

SOBHANI, NAVID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.516
EU - Europa 2.234
AS - Asia 1.803
SA - Sud America 208
AF - Africa 53
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.825
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.457
PL - Polonia 850
SG - Singapore 662
CN - Cina 448
IT - Italia 440
SE - Svezia 207
HK - Hong Kong 186
VN - Vietnam 160
BR - Brasile 159
DE - Germania 140
KR - Corea 93
IE - Irlanda 90
FR - Francia 82
GB - Regno Unito 80
RU - Federazione Russa 71
NL - Olanda 64
FI - Finlandia 61
IN - India 49
BD - Bangladesh 38
CA - Canada 38
UA - Ucraina 31
TR - Turchia 28
BG - Bulgaria 25
MA - Marocco 22
AR - Argentina 21
MY - Malesia 18
JP - Giappone 16
AT - Austria 13
ES - Italia 13
MX - Messico 13
PK - Pakistan 13
BE - Belgio 12
ZA - Sudafrica 12
IQ - Iraq 11
IR - Iran 11
ID - Indonesia 10
CH - Svizzera 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
JO - Giordania 7
RO - Romania 7
UZ - Uzbekistan 7
DZ - Algeria 6
EC - Ecuador 6
PH - Filippine 6
VE - Venezuela 6
MD - Moldavia 5
NZ - Nuova Zelanda 5
CL - Cile 4
IL - Israele 4
LT - Lituania 4
NP - Nepal 4
OM - Oman 4
PY - Paraguay 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
AU - Australia 3
CO - Colombia 3
HU - Ungheria 3
KE - Kenya 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PS - Palestinian Territory 2
SI - Slovenia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
WS - Samoa 1
Totale 7.824
Salva come PNG Salva come JPEG
Città #
Warsaw 817
Ashburn 425
Singapore 407
Fairfield 354
Chandler 214
Houston 200
San Jose 182
Hong Kong 180
Woodbridge 173
Seattle 140
Trieste 131
Ann Arbor 118
Cambridge 115
Wilmington 108
Beijing 102
Menlo Park 88
Seoul 86
Santa Clara 82
Hefei 80
Council Bluffs 68
Dallas 66
Boardman 63
Columbus 59
Princeton 49
Los Angeles 48
Chicago 46
Ho Chi Minh City 44
Helsinki 39
Lauterbourg 39
Jacksonville 38
Munich 35
Milan 34
Moscow 32
New York 32
Frankfurt am Main 31
Dublin 30
The Dalles 26
Hanoi 25
Zgierz 25
Sofia 24
Dearborn 22
Dong Ket 22
Buffalo 19
London 19
Orem 19
Redwood City 19
Izmir 18
Bremen 17
São Paulo 17
San Diego 16
Phoenix 15
Poplar 15
Atlanta 14
Casablanca 14
Denver 14
Duino-Aurisina 14
Toronto 13
Nuremberg 12
Shanghai 12
Tokyo 12
Amsterdam 11
Montegaldella 11
Boston 10
Brussels 10
Hangzhou 10
Tianjin 10
Turku 10
Da Nang 9
Lappeenranta 9
Rome 9
Chennai 8
Guangzhou 8
Johannesburg 8
Memphis 8
Mumbai 8
Nanjing 8
Redondo Beach 8
Udine 8
Amman 7
Decatur 7
Eagan 7
Genoa 7
Montreal 7
Redmond 7
Tehran 7
Düsseldorf 6
Florence 6
Kunming 6
Norwalk 6
Rio de Janeiro 6
Tashkent 6
Vienna 6
Belo Horizonte 5
Brooklyn 5
Cagliari 5
Changsha 5
Chisinau 5
Dongguan 5
Fuzhou 5
Lahore 5
Totale 5.472
Salva come PNG Salva come JPEG
Nome #
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma 455
Advances in systemic therapy for metastatic breast cancer: future perspectives 420
The predictive role of the immune system for response to therapy and survival in patients with solid tumors. 411
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? 395
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 368
Bevacizumab in small cell lung cancer 349
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 341
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 306
Corticosteroid switch after progression on abiraterone acetate plus prednisone 305
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 284
Advances in systemic therapy for malignant mesothelioma: Future perspectives 276
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy 267
Lenvatinib for the treatment of renal cell carcinoma 264
PROGNOSTIC ROLE OF TUMOR INFILTRATING LYMPHOCITES (TILS) IN EPITHELIOID PLEURAL MESOTHELIOMA 244
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 243
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 219
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer 197
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report 190
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 182
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy 166
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses 161
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair 157
Avelumab in gastric cancer 154
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 151
Mutant p53 as an antigen in cancer immunotherapy 139
Early changes of the standardized uptake values (SUVmax) predict the efficacy of everolimus-exemestane in patients with hormone receptor-positive metastatic breast cancer 125
Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer 124
Cancer management during the COVID-19 world pandemic 120
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 115
Cancer/testis antigens: from serology to mRNA cancer vaccine 109
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials 105
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer 99
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study 96
Immune-gene signature: A new tool for patient selection for checkpoint inhibitors? 86
Current Trends in Liquid Biopsy Tracking Resistance in Molecular Breast Cancer-Targeted Therapies 80
P53 antibodies as a diagnostic marker for cancer: A meta-analysis 76
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study 71
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer 71
The fibroblast growth factor receptors in breast cancer: From oncogenesis to better treatments 65
Totale 7.986
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.139
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 0 38
2021/2022448 31 42 43 37 10 38 26 14 53 61 17 76
2022/2023598 58 100 77 77 50 79 4 62 51 10 21 9
2023/2024530 13 67 57 45 33 43 103 84 2 26 31 26
2024/20251.278 13 123 186 95 97 118 68 56 156 141 104 121
2025/20262.421 239 150 149 287 235 206 305 83 209 336 142 80
Totale 7.986